Clinical Trial Results:
            Discontinuation of infliximab therapy in patients with Crohn’s disease during sustained complete remission: 
A Nordic multi-center, double blinded, randomized, placebo controlled study
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2012-002702-51 | 
    Trial protocol  | 
        DK SE FI NO | 
    Global completion date  | 
        |
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        |
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        |
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        |
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    17 Dec 2021
                             
         | 
    
    First version publication date  | 
        
                                    17 Dec 2021
                             
         | 
    
    Other versions  | 
        |
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.